Bridging Cognitive Aging in Rodents to Man Using fMRI in Amnestic MCI.

Trial Profile

Bridging Cognitive Aging in Rodents to Man Using fMRI in Amnestic MCI.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Aug 2017

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Alzheimer's disease; Mild cognitive impairment
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Mar 2015 According to Agenebio media release complete phase 2 results were published in Neurolmage: Clinical.
    • 31 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Mar 2012 Planned end date changed from 1 Oct 2011 to 1 Oct 2012 ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top